Weekly News Recap #Phispers
AbbVie inks US$ 5.6 bn oncology deal with China’s RemeGen; Astra buys Modella AI to speed up cancer drug research

AbbVie inks US$ 5.6 bn oncology deal with China’s RemeGen; Astra buys Modella AI to speed up cancer drug research

This week’s Phispers is packed with news from the ongoing JP Morgan Healthcare Conference (JPM26). Notably, AbbVie said i...

Impressions : 1611

Novartis inks US$ 5.2 bn cardiology deal with China’s Argo, US$ 2 bn deal with Arrowhead; FDA okays first GLP-1 generic for weight

Novartis inks US$ 5.2 bn cardiology deal with China’s Argo, US$ 2 bn deal with Arrowhead; FDA okays first GLP-1 generic for weight

Novartis signed two deals this week — a US$ 5.2 billion cardiology deal with China’s Argo Biopharmaceuticals, and a...

Impressions : 1233

GSK’s COPD, long-acting asthma drugs score late-stage wins;  Novo’s weight-loss drug Saxenda found to be safe in kids

GSK’s COPD, long-acting asthma drugs score late-stage wins; Novo’s weight-loss drug Saxenda found to be safe in kids

GSK scored a significant late-stage win with its asthma drug Nucala in treating chronic obstructive pulmonary disease (COPD). I...

Impressions : 1176

Boehringer boosts immune-oncology pipeline with US$ 1.3 bn Nerio buy; Pfizer adds US$ 1 bn to 2024 outlook

Boehringer boosts immune-oncology pipeline with US$ 1.3 bn Nerio buy; Pfizer adds US$ 1 bn to 2024 outlook

This week, the world’s largest private pharma company, Boehringer Ingelheim, acquired Nerio Therapeutics for up to US$ 1....

Impressions : 1180

Novo invests US$ 4.1 bn to boost Wegovy, Ozempic supply; Verona’s COPD therapy bags FDA nod

Novo invests US$ 4.1 bn to boost Wegovy, Ozempic supply; Verona’s COPD therapy bags FDA nod

This week saw a couple of developments in the lucrative US market for glucagon-like peptide-1 (GLP-1) drugs that treat diabetes...

Impressions : 1408

FDA raises cGMP concerns at Lupin’s US, India units; Sanofi begins hunt for new CEO

This week, Phispers brings you news about the CEOs of Sandoz and Sanofi. While Richard Francis, CEO of Novartis’ generi...

Impressions : 4163

FDA Updates List of Drugs with No Patents & No Competition; Approves First Marijuana Based Drug

This week Phispers has lots of news from the FDA. While the Trump administration announced its plans to reduce the jurisdicti...

Impressions : 5346